These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Evaluation of drug safety and efficacy. Hexachlorophene: Case in point. Introduction: the saga of hexachlorophene. Calesnick B J Clin Pharmacol; 1973; 13(11):437-8. PubMed ID: 4490667 [No Abstract] [Full Text] [Related]
13. The hex on, hex on hexachlorophene. Newman B Med Times; 1973 Feb; 101(2):33-40. PubMed ID: 4739317 [No Abstract] [Full Text] [Related]
14. Review of recent evidence of toxic effects of hexachlorophene. Kimbrough RD Pediatrics; 1973 Feb; 51(2):391-4. PubMed ID: 4267025 [No Abstract] [Full Text] [Related]
15. Hexachlorophene: is the FDA position justificable? Nordstrom FB Pediatrics; 1972 Mar; 49(3):464. PubMed ID: 5066921 [No Abstract] [Full Text] [Related]
16. Drugs (e.g., hexachlorophene), the FDA, and the AAP. Marks I Pediatrics; 1972 Aug; 50(2):338. PubMed ID: 5045363 [No Abstract] [Full Text] [Related]
17. Letter: In support of hexachlorophene. McCarl GW; Catapzno P Arch Dermatol; 1976 Jul; 112(7):1031-3. PubMed ID: 820268 [No Abstract] [Full Text] [Related]
18. Hexachlorophane and skin care of newborn infants. Plueckhahn VD Drugs; 1973; 5(2):97-107. PubMed ID: 4576494 [No Abstract] [Full Text] [Related]